CRISPR editing to Cure Blindness

Project by a team of Oregon Health & Science University

  • A team from Oregon Health & Science University used CRISPR-Cas9 for the first time in a human body to cure a rare form of blindness.
  • The medicine with CRISPR-Cas9 is developed by a biotech company Editas Medicine.
  • During this treatment the CRISPR-Cas9 enzymes were delivered in the eyeball with a fluid like eyedrops.

Used tech
CRISPR-Cas9, Gene Editing

Used for

Project stage
Pilot project

Case study

Charles Albright
Chief Scientific Officer of Editas Medicine

We literally have the potential to take people who are essentially blind and make them see. (…) We think it could open up a whole new set of medicines to go in and change your DNA.



Leave a Reply

Related Work